When was verzenio fda approved?

When did the FDA approve Verzenio (abemaciclib)?

Verzenio (abemaciclib) was approved by the FDA in 2017. [1]

Which Verzenio approval (indication) came first?

The FDA’s initial approval of Verzenio in 2017 covered its use in combination with an aromatase inhibitor for certain patients with hormone receptor–positive, HER2-negative advanced or metastatic breast cancer. [1]

Source

[1] https://www.drugpatentwatch.com/